dihydrotachysterol has been researched along with Polyuria* in 3 studies
3 other study(ies) available for dihydrotachysterol and Polyuria
Article | Year |
---|---|
Tumor necrosis factor-alpha induces renal cyclooxygenase-2 expression in response to hypercalcemia.
The effect of tumor necrosis factor-alpha (TNF) on cyclooxygenase-2 (COX-2) expression in the renal outer medulla (OM) was determined in a model of dihydrotachysterol (DHT)-induced hypercalcemia. Increases in serum calcium and water intake were observed during ingestion of a DHT-containing diet in both wild type (WT) and TNF deficient mice (TNF(-/-)). Polyuria and a decrease in body weight were observed in response to DHT treatment in WT and TNF(-/-) mice. A transient elevation in urinary TNF was observed in WT mice treated with DHT. Moreover, increased urinary levels of prostaglandin E(2) (PGE(2)) and a corresponding increase in COX-2 expression in the OM were observed in WT mice fed DHT. Increased COX-2 expression was not observed in TNF(-/-) mice fed DHT, and the characteristics of PGE(2) synthesis were distinct from those in WT mice. This study demonstrates that COX-2 expression in the OM, secondary to hypercalemia, is TNF-dependent. Topics: Animals; Cyclooxygenase 2; Dihydrotachysterol; Hypercalcemia; Kidney Medulla; Male; Mice; Polyuria; Tumor Necrosis Factor-alpha | 2012 |
Decreased aquaporin-2 expression and apical plasma membrane delivery in kidney collecting ducts of polyuric hypercalcemic rats.
Hypercalcemia is frequently associated with a urinary concentrating defect and overt polyuria. The molecular mechanisms underlying this defect are poorly understood. Dysregulation of aquaporin-2 (AQP2), the predominant vasopressin-regulated water channel, is known to be associated with a range of congenital and acquired water balance disorders including nephrogenic diabetes insipidus and states of water retention. This study examines the effect of hypercalcemia on the expression of AQP2 in rat kidney. Rats were treated orally for 7 d with dihydrotachysterol, which produced significant hypercalcemia with a 15 +/- 2% increase in plasma calcium concentration. Immunoblotting and densitometry of membrane fractions revealed a significant decrease in AQP2 expression in kidney inner medulla of hypercalcemic rats to 45.7 +/- 6.8% (n = 11) of control levels (100 +/- 12%, n = 9). A similar reduction in AQP2 expression was seen in cortex (36.9 +/- 4.2% of control levels, n = 6). Urine production increased in parallel, from 11.3 +/- 1.4 to a maximum of 25.3 +/- 1.9 ml/d (P < 0.01), whereas urine osmolality decreased from 2007 +/- 186 mosmol/kg x H2O to 925 +/- 103 mosmol/kg x H2O (P < 0.01). Immunocytochemistry confirmed a decrease in total AQP2 labeling of collecting duct principal cells from kidneys of hypercalcemic rats, and reduced apical labeling. Immunoelectron microscopy demonstrated a significant reduction in AQP2 labeling of the apical plasma membrane, consistent with the development of polyuria. In summary, the results strongly suggest that AQP2 downregulation and reduced apical plasma membrane delivery of AQP2 play important roles in the development of polyuria in association with hypercalcemia. Topics: Animals; Aquaporin 2; Aquaporin 6; Aquaporins; Body Water; Cell Polarity; Dihydrotachysterol; Diuresis; Hypercalcemia; Immunoenzyme Techniques; Kidney Cortex; Kidney Medulla; Kidney Tubules, Collecting; Male; Microscopy, Immunoelectron; Osmolar Concentration; Polyuria; Rats; Rats, Wistar; RNA, Messenger; Subcellular Fractions; Urine | 1998 |
[Hyperparathyroidism].
Topics: Adult; Bone Diseases; Calcium; Dihydrotachysterol; Female; Humans; Hypercalcemia; Hyperparathyroidism; Hypokalemia; Lactates; Male; Middle Aged; Polyuria; Prednisolone; Sodium; Sulfates; Urinary Calculi | 1971 |